Yokohama, Japan

Yoshiaki Motoki

This inventor holds 1 USPTO granted patent. Top assignee: Pola Chemical Industries Inc., Japan. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiaki Motoki. Retrieved from https://idiyas.com/inventor/yoshiaki-motoki-cinm3orn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoshiaki Motoki: Innovator in Pharmaceutical Chemistry

Introduction

Yoshiaki Motoki is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications.

Latest Patents

Motoki holds a patent for a Pyrrolo(3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine. This patent describes compounds that exhibit excellent circulatory disease curing activities as well as bronchodilation activities. The compounds are represented by a specific formula, wherein various substituents can be present, enhancing their therapeutic potential.

Career Highlights

Motoki is associated with Pola Chemical Industries Inc., a reputable company in Japan. His work focuses on the synthesis and application of novel chemical compounds that can address critical health issues.

Collaborations

Throughout his career, Motoki has collaborated with notable colleagues, including Michihiko Tsujitani and Kenichi Kishii. These collaborations have contributed to the advancement of research and development in their field.

Conclusion

Yoshiaki Motoki's innovative work in pharmaceutical chemistry, particularly his patented compounds, showcases his commitment to improving health outcomes through scientific research. His contributions continue to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…